SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-061771
Filing Date
2021-05-05
Accepted
2021-05-05 16:35:45
Documents
50
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111672d1_10q.htm 10-Q 459517
2 EXHIBIT 31.1 tm2111672d1_ex31-1.htm EX-31.1 10283
3 EXHIBIT 32.1 tm2111672d1_ex32-1.htm EX-32.1 4733
10 GRAPHIC tm2111672d1_10qimg01.jpg GRAPHIC 126501
  Complete submission text file 0001104659-21-061771.txt   4147445

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT syn-20210331.xml EX-101.INS 946957
5 XBRL TAXONOMY EXTENSION SCHEMA syn-20210331.xsd EX-101.SCH 35500
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20210331_cal.xml EX-101.CAL 37860
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20210331_def.xml EX-101.DEF 132494
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20210331_lab.xml EX-101.LAB 286555
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20210331_pre.xml EX-101.PRE 249468
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 21893987
SIC: 2834 Pharmaceutical Preparations